BioCardia, Inc. (BCDA): Cost of Revenue
Older than the company's other figures. The latest Cost of Revenue is for the year ended 2021-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$0
Year ended 2021-12-31
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2021-12-31 | $0 | -100.0% | 2022-03-29, From 2021-01-01 |
| 2020-12-31 | $4.0K | -98.9% | 2022-03-29, From 2020-01-01 |
| 2019-12-31 | $358.0K | -30.8% | 2021-03-30, From 2019-01-01 |
| 2018-12-31 | $517.0K | -25.1% | 2020-04-09, From 2018-01-01 |
| 2017-12-31 | $690.0K | -7.5% | 2020-04-09, From 2017-01-01 |
| 2016-12-31 | $746.0K | -29.7% | 2019-04-02, From 2016-01-01 |
| 2015-12-31 | $1.06M | n/a | 2018-03-16, From 2015-01-01 |